Drugs / Oral Vancomycin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07207434 Comparator | Aug 2025 → Aug 2026 overdue | — | Aga Khan University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oral Vancomycin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07207434 ↗ |
| Route | Oral | “Oral vancomycin in capsule form will be administered three times daily for 5 days at 250mg per dose.” NCT07207434 ↗ |